• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment


2.857 EUR 0.034 1.18%

As of 13:54:18 ET on 08/29/2014.

Snapshot for Sequenom Inc (QNMA)

Open: 2.892 Day's Range: 2.848 - 2.908 Volume: 1,000
Previous Close: 2.891 52wk Range: 1.190 - 3.057 1-Yr Rtn: +31.06%

Stock Chart for QNMA

No chart data available.
  • QNMA:GR 2.857
  • 1D
  • 1M
  • 1Y
Interactive QNMA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QNMA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.3300
Est. PEG Ratio -
Market Cap (M EUR) 333.33
Shares Outstanding (M) 116.67
30 Day Average Volume 393
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QNMA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for QNMA

Sequenom Inc. is a molecular diagnostic testing and genetics analysis company. The Company provides services, diagnostic testing, applications and genetic analysis products. Sequenom's products translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research.

Dirk Van Den BoomChief Scientific & Strategy OfcrR William Bowen "Bill"Senior VP/Secy/General Counsel
A Michael MonkoSenior VP:Genetic AnalysisRobin G WeinerSenior VP:Quality
More Company Profile & Key Executives for QNMA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil